The New Power of Routines
Personal care is more than cosmetics – it’s becoming a global foundation for health, well-being, and prevention. A new study reveals how routines are changing lives.
100 days of ePA: Awareness stagnates, usage remains low
100 days after its launch, Germany’s electronic health record (ePA) is only used by a small number of insured persons. Technical barriers and lack of information slow down progress.
Norgine completes acquisition of Theravia
Norgine has successfully completed the acquisition of Theravia, strengthening its rare disease portfolio and market presence across Europe and ANZ.
DKV Report 2025: Germany on the Move Too Little
The DKV Report 2025 reveals alarming trends in Germany’s health behavior: only 2% of the population meets all the benchmarks for a healthy lifestyle. Lack of exercise, chronic stress and excessive sitting are major concerns.
New Look, Trusted Quality: sebamed Relaunch 2025
Starting in August 2025, sebamed presents a modern packaging redesign that combines transparency, medical expertise, and sustainability – with the same trusted quality.
Alarming Stress Levels Among Primary School Children
A new study shows that even primary school children are under significant stress. Academic pressure, bullying, and media use are major contributors.
Gen Z Trusts AI for Health Decisions
The new Better Health Report 2025 from Simon-Kucher and AESGP reveals a digital shift in prevention: AI is becoming a trusted tool in self-care – especially for Gen Z.
BPI launches Radiopharmaceuticals Working Group
BPI has launched the Radiopharmaceuticals Working Group to foster exchange on regulatory, scientific, and healthcare policy challenges in this innovative drug class.
Publicis Health Acquires p-value Group
Publicis Health strengthens its medical communications capabilities across the full product lifecycle by acquiring p-value Group.
Strong Commitment to Cancer Care: Cancer Aid Releases Report
In 2024, German Cancer Aid launched 164 new cancer-fighting projects funded by €181 million in donations – including research, new care models, and patient support.
Pharmacy Day 2026: Save the Date!
On March 25, 2026, the Thuringian Chamber of Pharmacists invites students to the Pharmacy Day in Jena. Under the motto “Your Prescription for Life”, participants will gain exciting insights into the pharmacy profession.
Takeda Relocates German HQ to Berlin
Takeda is relocating the headquarters of Takeda GmbH from Konstanz to Berlin, focusing future operations on Berlin, Oranienburg, and Singen.
Campaign Germany: Submit now for Agency of the Year 2025!
The Campaign Germany Agency of the Year Awards honor the best agencies and standout individuals – submissions open until July 25, 2025!
Nordic Capital and Permira plan takeover of Bavarian Nordic
A consortium led by Nordic Capital and Permira plans to acquire Danish vaccine company Bavarian Nordic in a deal worth around DKK 19 billion.
Pharmacy Crisis Intensifies
The number of pharmacies in Germany has continued to fall sharply in the first half of 2025. The ABDA warns of serious consequences for healthcare delivery.
Engelhard excels with top-rated training program
Engelhard secures 1st place in the 2024 OTC Performance Review in the "Training Program" category – thanks to innovative formats like Selfcare Saturdays and the “Engelhard & Me” app.
Sustainability becomes central to medical care
Sustainability is becoming an increasingly important factor in therapy decisions for physicians in Germany. This is shown by the new Physician Barometer commissioned by AstraZeneca.
Kling Bio partners with Sanofi
Kling Bio partners with Sanofi to discover novel, high-potency antibodies for combating viral diseases using its proprietary Kling-Select B cell platform.
Biotech 2025: Precision Drives Progress
The new Biotech Report 2025 shows: Biopharmaceuticals dominate the market while precision medicine is transforming healthcare. Germany remains a hub for innovation.
medac and Clinigen strengthen APAC cooperation
medac and Clinigen expand their collaboration in the APAC region – six key therapies will be exclusively marketed and distributed.